EU regulators move up Pfizer vaccine assessment to Dec. 21
BERLIN (AP) — Facing strong pressure from Germany and other European Union nations, the bloc's medicines agency on Tuesday moved up a meeting to assess the Pfizer-BioNTech coronavirus vaccine to Dec. 21, likely bringing vaccinations a step closer for millions of EU citizens.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
